Skip to main content

Quoin Pharmaceuticals Ltd S-3, filed Oct 28, 2026

Quoin Pharmaceuticals Ltd. (QNRX)

Quoin Pharmaceuticals Ltd. filed a shelf registration statement allowing it to offer up to $150,000,000 in ordinary shares represented by ADSs, warrants, subscription rights, debt securities and units. As of October 23, 2026, the public float was approximately $36,422,384, and while it remains below $75.0 million, the company may not sell securities in a public primary offering exceeding more than one-third of that float in any 12-month period. AI summary

S-3 2026-10-28
View Original
Added on October 28, 2026